The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee February 2026 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
The following new shared care guidelines were approved and can be found at:
- NENC Shared Care Protocol – Atomoxetine for patients within adult services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Atomoxetine for patients within children’s services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Dexamfetamine for patients within adult services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Dexamfetamine for patients within children’s services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Guanfacine for patients within adult services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Guanfacine for patients within children’s services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Lisdexamfetamine for patients within adult services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Lisdexamfetamine for patients within children’s services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Methylphenidate for patients within adult services https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Methylphenidate for patients within children’s services https://ntag.nhs.uk/shared-care-guidelines/